首页> 美国卫生研究院文献>Molecular Therapy. Nucleic Acids >CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects
【2h】

CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects

机译:人类干细胞中的CRISPR / Cas9基因组编辑系统:现状和未来展望

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Genome-editing involves the insertion, deletion, or replacement of DNA in the genome of a living organism using “molecular scissors.” Traditional genome editing with engineered nucleases for human stem cells is limited by its low efficiency, high cost, and poor specificity. The CRISPR system has recently emerged as a powerful gene manipulation technique with advantages of high editing efficiency and low cost. Although this technique offers huge potential for gene manipulation in various organisms ranging from prokaryotes to higher mammals, there remain many challenges in human stem cell research. In this review, we highlight the basic biology and application of the CRISPR/Cas9 system in current human stem cell research, discuss its advantages and challenges, and debate the future prospects for human stem cells in regenerative medicine.
机译:基因组编辑涉及使用“分子剪刀”在活生物体的基因组中插入,删除或替换DNA。用人类干细胞用工程核酸酶进行的传统基因组编辑受到效率低,成本高和特异性差的限制。 CRISPR系统最近成为一种强大的基因操作技术,具有编辑效率高和成本低的优点。尽管这项技术为从原核生物到高等哺乳动物的各种生物提供了基因操纵的巨大潜力,但在人类干细胞研究中仍然存在许多挑战。在这篇综述中,我们重点介绍了CRISPR / Cas9系统在当前人类干细胞研究中的基本生物学和应用,讨论了其优势和挑战,并讨论了人类干细胞在再生医学中的未来前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号